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Abstract
Male hamsters (30 per group) were fed five different semi-purified diets ad libitum. The diets, containing 30% of energy (en%)
as fat, differed in their dietary fat composition (specified fatty acids exchanged at 10 en%) and were fed for 4 weeks. The five fatty
acids compared in mixed triglycerides were elaidic acid (C18:1 9t), vaccenic acid (C18:1 11t), their cis-counterpart oleic acid
(C18:1 9c), medium-chain fatty acids (MCFA; C8:0 and C10:0), and palmitic acid (C16:0). Compared with oleic acid, dietary
MCFA and palmitic acid tended to increase blood cholesterol levels in the hamsters. The effect of elaidic and vaccenic acid on
blood cholesterol did not differ from that of oleic acid. When elaidic acid and vaccenic acids were compared directly, the ratio
of LDL/HDL-cholesterol in plasma was significantly higher in hamsters fed vaccenic acid than in those fed elaidic acid, and
elaidic acid was incorporated at low levels, but more efficiently than vaccenic acid at the sn-2 position of platelet phospholipids.
Biological consequences of this low incorporation are considered unlikely as levels of arachidonic acid (C20:4 n-6) and
docosohexaenoic acid (C22:6 n-3) in the platelet phospholipids of all dietary groups did not differ. With respect to the effect on
the LDL/HDL-cholesterol ratio, elaidic acid may be preferable to vaccenic acid. We conclude that this animal study does not
provide evidence for the suggestion, based on epidemiological observations, that elaidic acid would be more detrimental to
cardiovascular risk than vaccenic acid. © 2001 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Epidemiological studies in the United States of
America have suggested that dietary trans-fatty acids
from partially hydrogenated vegetable oils, as found in
margarine, but not those from ruminant fats, present in
butter, are associated with an increased risk of coro-
nary heart disease in women [1,2]. Moreover, in the
Scottish Heart Health Study dietary intake of total or
partially hydrogenated vegetable oils-derived trans-fatty
acids, but not of naturally occurring trans-fatty acids
(mainly ruminant), tended to be positively associated
with risk of coronary heart disease in women [3]. The
observed difference in effect of the two types of trans-
fatty acids on risk of coronary heart disease is at-
tributed to the distinct structure of the primary
trans-isomer in ruminant fat, i.e. vaccenic acid, which
has the double bond at the 11 as opposed to the 9
position in elaidic acid, the predominant but not exclu-
sive trans-isomer in partially hydrogenated vegetable
oils. However, there is no clear biological explanation
for such a differential effect. In human skin fibroblasts,
elaidic acid has been shown to be a more potent
inhibitor of 6-desaturase in vitro than vaccenic acid
[4], whereas the opposite was observed in rat liver
microsomes [5]. These findings, however, can not di-
rectly be related to coronary heart disease.
No metabolic studies have been published in which
elaidic acid is directly compared with vaccenic acid in
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dietary triglycerides. In the present study both trans-
fatty acids were therefore compared in hamsters with
their cis-counterpart oleic acid; medium-chain fatty
acids, which have been reported to have neutral ef-
fects on blood lipids [6]; and palmitic acid, which is
hypercholesterolemic in the hamster [6]. The average
human trans-fatty acids intake (as mixture of iso-
mers) is around 2% of energy (en%) [7]. The intake
of the two trans-fatty acids isomers in this experiment
was set at the high level of 10 en% to enable detec-
tion of differential effects, if any. The hamster was
used as an animal model because lipid metabolism in
this rodent species resembles human lipid metabolism
more than that in rats or mice [8,9]. Elaidic acid and
vaccenic acid were each randomly incorporated in di-
etary triglycerides.
Theoretically, the two trans-fatty acids could have
a differential impact on lipid and eicosanoid
metabolism in vivo, which in turn could explain a
differential effect on coronary heart disease risk, if
any. In the current study those aspects of lipid and
eicosanoid metabolism were investigated that either
have been reported, or were considered most likely to
be effected by trans-fatty acid intake. The parameters
measured were plasma lipids and lipoproteins, lipid
transfer and transferase protein activities. In man di-
etary trans-fatty acids have been reported to simulta-
neously increase LDL-cholesterol and decrease
HDL-cholesterol, or at least to raise the ratio LDL/
HDL-cholesterol, when compared with oleic acid [10].
Lecithin:cholesterol acyltransferase (LCAT) and phos-
pholipid transfer protein (PLTP) are HDL-bound en-
zymes. Previous studies have shown that cholesteryl
ester transfer protein (CETP) activity, measured either
with endogenous [11] or exogenous [12] substrates,
may be affected by dietary trans-fatty acids in hu-
mans. To predict whether the two trans-fatty acids
would have the potential to differentially affect ei-
cosanoid metabolism [1], the fatty acid distribution in
phospholipids was also determined.
2. Materials and methods
2.1. Animals and design
The experimental protocol was approved by the
Animal Experiments Committee of the Unilever Re-
search Laboratory, Vlaardingen, The Netherlands.
A total of 150 male F1B hybrid Syrian (golden)
hamsters, aged 10–11 weeks at arrival, were obtained
from Biobreeder Inc., Fitchburg, US. The study was
designed to have a large statistical power to be able
to detect small differences between dietary treatments.
The hamsters were housed individually in
Makrolon cages type II, with a layer of sawdust as
bedding, in a room with controlled lighting (light,
07:00–19:00 h), temperature (22–24°C) and relative
humidity (45–65%). After an adaptation period of 3
weeks, plasma cholesterol concentration was deter-
mined and the hamsters were allocated to five groups
of 30 animals each on the basis of similar means and
distributions of plasma total cholesterol concentration
and body weight. Five different diets were fed during
four weeks. Body weight was measured weekly and
food consumption was determined during four con-
secutive days in the second and the last week of the
experiment. Non-fasted hamsters were anaesthetized
with a mixture of N2O/O2/Halothane, killed by de-
capitation after blood sampling by orbital puncture,
and autopsy was performed subsequently.
2.2. Dietary fats and diets
Elaidic acid (trans-9-octadecenoic acid; E-4637) and
vaccenic acid (trans-11-octadecenoic acid; V-1131)
were obtained from Sigma Chemicals (US). Five test
fats (blends) were prepared, which differed in their
fatty acid composition. A fat blend rich in medium-
chain fatty acids (MCFA) was obtained by mixing
33.3% medium chain triglycerides-oil (Ceres MCT,
Union Deutsche Lebensmittel Werke GmbH, Kleve,
Germany), 6.0% cacao butter, 13.7% dry-fractionated
palm oil-stearin fraction, 2.4% linseed oil, 13.7%
safflower oil, plus 30.9% high-oleic sunflower oil
(Trisun-80, SVO, OH, US). A fat blend rich in
palmitic acid (SAFA) was prepared by mixing 53.2%
wet-fractionated palm oil-stearin fraction, 2.3% lin-
seed oil, 17.3% safflower oil, plus 27.2% high-oleic
sunflower oil (Trisun-Extra, SVO). An oleic-acid rich
fat blend (MUFA) was obtained by mixing 2.1% lin-
seed oil, 9.8% wet-fractionated palm oil-stearin frac-
tion, 10.3% sunflower oil, plus 77.8% Trisun-80.
Triglycerides rich in elaidic acid (Elaidic) were pre-
pared by mixing 33% free elaidic acid and 67% of a
hydrolyzed fat blend (9.3% cocoa butter, 7.5% fully
refined olive oil, 22.2% palm oil, 28.4% soy bean oil,
plus 32.6% Trisun-80). Similarly, triglycerides rich in
vaccenic acid (Vaccenic) were prepared by mixing
33% free vaccenic acid and 67% of the same hy-
drolyzed fat blend as used for the ‘Elaidic’ fat. The
two trans-fatty acids-containing fat blends were pre-
pared by heating the hydrolyzed fat blend, the free
trans-fatty acid, glycerol, and titanium tetra butoxide
as a catalyst, with toluene. Esterification was driven
towards the formation of triglycerides by gradual re-
moval of water and toluene during temperature pro-
gramming. Care was taken to prevent
trans-esterification reactions (formation of -keto es-
ters). Free fatty acids were removed by washing, silica
refining, and steaming.
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Table 1
Composition of the five experimental diets
g/1000 kJDiet component g/100 g en (kJ) en%
23.565Calcium caseinate 230.114.64 23.0
13.038Fat blenda 299.78.1 30.0
55.404 469.834.42 47.0Maize starch
3.9Solkafloc 6.278
0.86Mineral mix RMH89b 1.384
0.3220.2Vitamin mix Vit90c
0.010Cholesterol 0.006
100.001 999.662.126 100.0Total
a See Section 2.2.
b Composition in mg/MJ, primary potassium phosphate; K2HPO4,
112.89; potassium bicarbonate, KHCO3, 170.88; potassium chloride,
KCl, 83.18; calcium carbonate, CaCO3, 70.11; secondary magnesium
phosphate, MgHPO4 · 3H2O, 227.21; tri-sodium citrate-dihydrate,
Na3C6H5O7 · 2H2O, 168.98; manganese sulfate, MnSO4 · H2O, 12.22;
ferric citrate (19% Fe), FeC6H5O7 · 5H2O, 10.43; copper citrate (35%
Cu), CuC6H6O7 ·×H2O, 1.12; zinc citrate, Zn3(C6H5O7)2 · 3H2O,
2.97; potassium iodate, KIO3, 0.017.
c Composition in mg/MJ, thiamin mono-nitrate, 0.36; riboflavin,
0.36; nicotinamide, 1.20; calcium pantothenate, 1.20; choline chloride
50%, 119.5; myo-inositol, 5.98; folic acid, 0.06; biotin, 0.012; pyridox-
ine, 0.38; vitamin B12, 3.10; vitamin A (325 IU/mg), 1.84; vitamin D3
(1000 IU/mg), 0.60; vitamin K3 (22.7%), 0.24; dl--tocopherol (dry
powder 50%), 9.56; calcium silicate, 11.95; sucrose, 43.658.
a modest degree of hyperlipoproteinemia to enhance
the effects of the dietary fatty acids on lipoprotein
levels [13]. The exchange of the indicated fatty acid was
fixed at a level of 10 en%, at the expense of oleic acid.
The concentration of fat and the fatty acid composition
of the dietary fats in the experimental diets were mea-
sured in each test diet, directly following production.
Concentration of fat in the experimental diets was
determined by extraction with dichloromethane after
lyophilization. In the test fats the fatty acid distribution
was determined (Table 2) with special emphasis on
trans-isomers, using a 50 m column and an optimized
temperature program [14]. In addition, in the experi-
mental diets fatty acid distribution was determined
using a standard method [15], immediately following
production and after storage of the diets for 4 weeks, to
check stability. All diets were prepared once. Portions
of each diet for feeding during 2–3 day periods were
stored at −20°C under an atmosphere of N2 until use.
The diets were fed in powdered form. During the
adaptation period all hamsters were fed ad libitum with
the MUFA diet.
2.3. Analyses
At the end of the experiment, plasma (EDTA as
anti-coagulant) lipoproteins VLDL (plus IDL), LDL,
and HDL were separated according to the method of
The diets were fed ad libitum, and contained 30 en%
as fat and a background level of 0.01% cholesterol
(Table 1). Cholesterol was added to the diets to induce
Table 2
Analyzed fatty acid composition of the five dietary fat blendsa
MCFA SAFA MUFAFatty acid Elaidic Vaccenic
(g/100 g)
C8:0 15.3 0 0 0 0
13.0 0C10:0 0 0 0
0.1 0C12:0 000.1
0.2 0.8C14:0 0.2 0.2 0.2
11.711.844.5 11.712.6C16:0
5.1 4.7C18:0 4.6 4.8 4.8
33.7 0.1C18:1 9t 0 0.1 0
000C18:1 11t 34.00.3
34.9 32.732.765.732.3C18:1 9c
15.4 14.1C18:2 9c,12c 14.1 13.5 13.5
0.91.31.31.5 1.0C18:3 9c,12c,15c
0.4 0.40.3C20:0 0.3 0.3
C20:1 0.10.1 0.10.10.2
C22:0 0.30.30.90.40.4
0.2 0.2C24:0 0.3 0.1 0.1
98.6 98.8Total 99.1 99.0 99.5
(en%)
0.0 0.0 0.0 0.08.5MCFA
15.3 5.5 5.2 5.25.7SAFA
9.89.819.8MUFA 9.710.5
0.0 0.0 10.2 10.20.0Trans-fatty acids
4.65.1 4.4PUFA 4.34.6
29.629.629.929.7Total 29.7
a For description of the five fat blends, see Section 2.2.
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Pietsch et al. [16]. Plasma was combined for each
group in 12 pools of two randomly selected animals
each. In the lipoprotein fractions, total and free
cholesterol (CHOD-PAP method, Boehringer,
Mannheim, Germany), triglycerides (GPO-PAP
method, Roche, Basel, Switzerland), phospholipids
(Boehringer), and protein [17] (not in HDL because
of the albumin present in this fraction) were deter-
mined, using commercially available reagent kits on a
Cobas Mira S automated analyzer (Roche). The con-
centration of cholesteryl esters was calculated as the
difference between total and free cholesterol concen-
trations. In all animals (n=30 per group) total
cholesterol (Boehringer) was measured in whole
(EDTA-)plasma before allocation and at the end of
the experiment.
CETP activity level was assayed in EDTA-plasma
according to Groener et al. [18] with modifications as
described earlier [19]. Lecithin:cholesterol acyltrans-
ferase (LCAT) activity levels were determined in
EDTA-plasma as originally described [20], using the
modifications as described [19]. Plasma phospholipid
transfer protein (PLTP) activity level was measured as
described [21]. CETP, LCAT and PLTP activities
were expressed in arbitrary units, i.e. relative to the
activity in a human plasma pool (% of plasma pool).
Liver total and free cholesterol concentrations were
determined as described [22]. From liver homogenate,
cholesteryl esters were isolated after extraction ac-
cording to Folch et al. [23] and separation over a
column packed with silica gel. The fatty acid distribu-
tion of the liver cholesteryl esters was determined by
gas chromatography [15]. Platelets were obtained
from platelet-rich plasma, washed in saline, and
platelet phospholipids were isolated on a silica
column. In three pools of eight animals each per
group, the overall and sn-2 position distribution of
fatty acids in phospholipids were determined by gas
chromatography [15]. Fatty acids from the sn-2 posi-
tion were hydrolyzed by phospholipase-A2 (Sigma P-
9279) from bee venom.
At dissection, macroscopic examination was per-
formed and liver samples were fixed in formalin, and
stained with haematoxylin and eosin for microscopic
examination.
2.4. Statistics
Data are expressed as meanS.E.M. Statistical
analysis was performed using the SAS computer pro-
gram, version 6.10. One-way analysis of variance
(ANOVA) was performed on the parameters mea-
sured or, if the data were not distributed normally,
the Kruskal–Wallis test was used. The Student–New-
man–Keul’s multiple comparison test was used to an-
alyze differences between treatment means. The
two-sided level of statistical significance was pre-set at
P0.05.
3. Results
3.1. Diets
As intended, detailed analysis of the fatty acid pat-
tern in the dietary fat blends revealed that the
MCFA, SAFA, MUFA, Elaidic, and Vaccenic fats
were increased with 28–34% of caprylic (octanoic)
and capric (decanoic), palmitic (hexadecanoic), oleic
(9c-octadecenoic), elaidic, and vaccenic acid, respec-
tively (Table 2). The fatty acid patterns include fatty
acids from mono- and di-acylglycerols and unes-
terified fatty acids, which were typically present at
levels of 0.1, 5, and 0.1%, respectively. The
fatty acid composition of the five experimental diets
showed a great similarity with the fatty acid profiles
of the five experimental fats (data not shown). The
dietary fat content varied between 13.1 and 13.7 g/
100 g diet (data not shown). Based on the stability of
the fatty acid profiles, as analyzed in the diets after
storage for four weeks, no deterioration of fatty acids
was observed (data not shown).
3.2. Animal performance
Clinical observation of the hamsters revealed no
abnormalities before and during the study. Body
weight was measured weekly and growth was calcu-
lated as the change in body weight from the start of
the study. Feed intake was measured during four con-
secutive days in the second and the last week of the
experiment. No systematical differences in animal
growth and feed intake between the dietary groups
were observed (data not shown). This indicates that
energy absorption and use must have been similar in
all dietary groups. Since the diets differed only in
their fatty acid composition, it can also be concluded
that fat absorption must have been similar in all the
groups.
At the end of the experiment, macroscopic evalua-
tion revealed very slightly pale livers, and a more
pronounced lobular pattern, which was more abun-
dant in hamsters fed the MUFA, Elaidic or Vaccenic
diets (P0.02; data not shown). This paleness can be
attributed to fat deposition in the hepatocytes. Micro-
scopically, a slight vacuolation was observed in hepa-
tocytes from hamsters of all groups. Vacuolation was
not accompanied by fibrosis or necrosis, and can
therefore be considered as reversible. Inflammatory
cell infiltrates, mostly consisting of mononuclear cells,
were observed to a similar extent in all the dietary
groups. We concluded that there were no distinct
pathological effects observed in this study.
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Table 3
Plasma cholesterol, lipid transfer and transferase proteins activity levels and liver cholesterol concentrations in the five experimental groups
MCFAMeasure SAFA MUFA Elaidic Vaccenic ANOVA
Plasma
Total Cholesterol (mM)c
3.910.09aStart 3.910.09a3.910.09a 3.900.09a 3.910.09a 0.999
4.190.14a 3.760.13ab 3.670.11b3.940.14ab 3.950.13abEnd 0.053
1.270.04a 1.110.04b 1.050.03bFree cholesterol (mM)d 1.170.04ab1.150.04ab 0.001
2.930.10a 2.650.09a 2.610.08a2.790.11a 2.780.10aEsterified cholesterol (mM)d 0.163
984.5aCETP (%)c 964.7a 944.0a 963.8a 954.3a 0.969
1473.5a 1413.5ab 1322.9b1373.4ab 1474.4aLCAT (%)c 0.012
852.0b 761.7a 751.2a 801.8aPLTP (%)c 0.001771.7a
Lier
10.00.77bTotal cholesterol (mol/g)d 12.20.68ab11.50.65ab 13.40.88a 12.40.55ab 0.015
Free cholesterol (mol/g)d 7.70.35ab 6.80.39b 7.90.40ab 8.40.53a 7.90.31ab 0.087
3.20.41b 4.20.30ab 5.10.37a3.80.33ab 4.60.28aEsterified cholesterol (mol/g)d 0.002
ab Groups not sharing the same superscript letter differ statistically significantly (P0.05, Student–Newman–Keul’s test).
c Value for n=30 hamsters per group.
d Value for n=24 hamsters per group, expressed per g wet weight.Arbitrary unit, i.e. relative to the activity in a human plasma pool (% of
plasma pool).
Table 4
Cholesterol and triglycerides in plasma lipoproteins of the five experimental groupsd
Measure SAFAMCFA MUFA Elaidic Vaccenic ANOVA
Total cholesterol (mM)
0.750.073aVLDLe 0.730.050a0.710.042a 0.600.034a 0.660.057a 0.313
1.160.081aLDL 0.910.033b1.030.031ab 0.860.028b 1.030.046ab 0.001
1.560.061a 1.480.054a 1.520.053a1.530.051a 1.520.059aHDL 0.891
0.670.010abLDL/HDL 0.700.028a 0.620.017bc 0.570.016c 0.650.018ab 0.001
82.41.1a 82.90.61a 81.20.96a83.10.56a 81.61.3aRecoveryf 0.542
Triglycerides (mM)
1.570.145a 1.270.120ab 0.970.063b1.310.085ab 1.230.103abVLDLe 0.007
0.0990.006bLDL 0.0760.004a0.0820.005a 0.0700.003a 0.0710.007a 0.001
0.0730.005a 0.0690.004a 0.0640.004a0.0700.005a 0.0670.005aHDL 0.741
abc Groups not sharing the same superscript letter differ statistically significantly (P0.05, Student–Newman–Keul’s test).
d Analyses were performed in 12 pools (of two hamsters each) per group.
e Includes IDL.
f Recovery was calculated as the sum of total cholesterol in (VLDL+LDL+HDL) expressed as percent of total cholesterol in whole plasma.
3.3. Plasma lipids, lipoproteins and lipid transfer
proteins
Plasma total cholesterol levels tended to be highest in
the hamsters fed the SAFA diet and lowest in the
hamsters fed the Elaidic diet (Table 3). Only the differ-
ence between these two groups was statistically signifi-
cant. This pattern was reflected in free as well as in
esterified cholesterol levels. There were no differences in
cholesterol levels between the two groups fed the
Vaccenic or the Elaidic diet. Separation of plasma
lipoproteins was satisfactory, since calculated recovery
for total cholesterol was 80% and there were no
differences in recovery between the groups. The five
dietary groups did not differ significantly in their
VLDL-cholesterol concentration, nor in their HDL-
cholesterol concentration (Table 4). The differences in
plasma total cholesterol concentration were mostly
reflected in LDL-cholesterol levels. LDL-cholesterol in
the hamsters fed the MUFA diet was significantly lower
than that in the hamsters fed the SAFA diet. The ratio
of LDL:HDL-cholesterol was lower in the hamsters fed
the MUFA or Elaidic diets than in those fed the
MCFA, SAFA, or Vaccenic diet (Table 4). However,
this ratio was statistically significantly lower only in the
groups fed the MUFA or Elaidic diet than in the
hamsters fed the SAFA diet. VLDL-triglycerides level
was highest in hamsters fed the SAFA diet and lowest
in their Elaidic diet fed counterparts (Table 4). All
groups showed similar levels of CETP activity (Table
3). LCAT activity was highest in the hamsters fed the
SAFA or Vaccenic diet and lowest in those fed the
Elaidic diet. PLTP activity in the hamsters fed the
SAFA diet was significantly higher than in all other
G.W. Meijer et al. / Atherosclerosis 157 (2001) 31–4036
groups. VLDL of hamsters fed the MUFA or Elaidic
diet contained more cholesterol esters and less triglyce-
rides than VLDL of hamsters fed the SAFA diet (Table
5), which in turn contained more phospholipids than
those of hamsters fed the Elaidic diet. The composition
of VLDL from hamsters fed the MCFA or Vaccenic
diet was intermediate. As compared with the Vaccenic
diet, feeding of the Elaidic diet resulted in VLDL that
contained more cholesteryl esters and less triglycerides
and phospholipids. A differential effect of the dietary
fats on LDL composition was only seen in the phos-
pholipids contents which was higher in LDL from
hamsters fed the SAFA diet than in LDL from ham-
sters fed the MUFA or Elaidic diet. LDL from ham-
sters fed the Vaccenic diet contained more
phospholipids than LDL from hamsters fed the Elaidic
diet. The ratio of cholesteryl esters over free cholesterol
in HDL was similar in all the dietary groups.
3.4. Lier lipids
Contrary to the levels in plasma, total cholesterol
concentration in the liver was highest in the hamsters
fed the Elaidic diet and lowest in those fed the SAFA
diet (Table 3); only this difference was statistically
significant. The same pattern was seen for free as well
as for esterified cholesterol levels. There were no differ-
ences between the two groups fed the two trans-fatty
acids diets.
The fatty acid profile of the liver cholesteryl-esters
differed largely among the five groups, which was in
agreement with the fatty acid composition of the diets
(Table 6). Myristic, palmitic (highest in the SAFA
group), and stearic acid concentrations were higher in
the groups fed the MCFA or SAFA diet. The highest
levels of oleic, elaidic, and vaccenic acid were observed
in the groups fed the MUFA, Elaidic, and Vaccenic
diet, respectively. The level of linoleic acid was lowest
in the hamsters fed the MUFA diet. These data demon-
strate that the various dietary fatty acids did reach the
liver, with the apparent exception for the MCFA as had
been anticipated [6]. MCFA are absorbed across the
intestinal mucosa and carried directly to the liver in the
portal circulation. There they are able to enter the
mitochondrial compartment, and are rapidly oxidized
to acetyl CoA and can then be used for the de novo
synthesis of long-chain fatty acids. Interestingly, conju-
gated linoleic acid (CLA; C18:2 9c,11t plus C18:2
9t,11c) was found in hepatic cholesteryl esters of ham-
sters fed the Vaccenic diet.
3.5. Platelet phospholipids
Total fatty acid composition, i.e. at the sn-1 and the
sn-2 positions, of platelet phospholipids revealed a
higher level of palmitic acid in the hamsters fed the
SAFA diet (Table 7). Feeding the Elaidic and Vaccenic
diets resulted in a significant incorporation of elaidic
acid and vaccenic acid, respectively, in phospholipids.
The level of linoleic acid in phospholipids tended to be
higher in the hamsters on the SAFA diet and lower in
the hamsters fed the MUFA diet. For the sn-2 position,
the fatty acid distribution did not differ among the five
groups. However, there was a small but statistically
significant incorporation of elaidic acid at the sn-2
position in the hamsters fed the Elaidic diet, whereas
Table 5
Chemical composition of plasma lipoproteins of the five experimental groupsd
ANOVAMUFASAFAMCFAMeasure Elaidic Vaccenic
VLDL (% of mass)
5.60.05a 5.70.12aFCe 5.60.14a5.70.05a 0.8505.60.10a
14.50.34a12.60.76b15.00.29aCE 16.00.51ac 0.00117.10.59c
60.30.90a58.40.45ab 0.001TG 58.10.57ab55.10.90c56.90.90bc
12.30.18a 13.10.17b 12.20.19aPL 11.40.20c 12.20.24a 0.001
Protein 8.70.37ab 8.30.53a 9.20.58ab 10.90.71b 9.60.72ab 0.036
LDL (% of mass)
9.20.20aFC 8.90.27a9.10.18a 8.80.12a 9.00.15a 0.728
34.00.59aCE 34.00.66a34.40.60a 34.80.68a 34.30.58a 0.895
0.3924.60.50a5.40.37a5.40.34aTG 5.80.51a5.20.39a
23.10.57a 21.00.50bc 20.40.46c 22.30.43abPL 0.00121.60.32abc
29.70.85a 28.00.94a 30.70.97aProtein 30.61.1a 29.80.94a 0.278
HDL
3.820.13a3.750.13a3.770.11a 3.730.08aCE/FC 3.600.13a 0.718
abc Groups not sharing the same superscript letter differ statistically significantly (P0.05, Student–Newman–Keul’s test).
d Analyses were performed in 12 pools (of two hamsters each) per group.
e Masses of lipids were calculated using the following molecular weights: free cholesterol (FC)=387 g/mol; cholesteryl esters (CE)=650 g/mol;
triglycerides (TG)=850 g/mol; phospholipids (PL)=775 g/mol.
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Table 6
Fatty acid composition (g/100 g) of liver cholesteryl esters in the five experimental groupsd
MCFA SAFA MUFAFatty acid Elaidic Vaccenic ANOVAe
0.560.04b 0.0010.630.04b1.20.24a1.00.17aC14:0 0.610.05b
223.9a 302.8b 131.2cC16:0 120.50c 151.9c 0.001
C18:0 5.60.74a 6.30.43a 3.60.20b 3.40.09b 4.20.33b 0.001
5.00.31 1 0.00111C18:1 9t 1
11C18:1 11t 1 1 0.0012.50.26
585.3a 0.001C18:1 9c 680.86ac722.0c483.0b 652.3ac
10.20.32d9.20.56c13.30.43b12.10.61abC18:2 9c,12c 0.00110.90.39ad
0.0013.20.3611C18:2 9c,11t/9t,11c 11
1 1 0.242C18:3 9c,12c,15c 1 1 1
1 1 0.363C20:0 1 1 1
0.002111C20:1 11
C22:0 0.50811111
abc Groups not sharing the same superscript letter differ statistically significantly (P0.05, Student–Newman–Keul’s test).
d Analyses were performed in eight randomly selected hamsters per dietary group.
e ANOVA after logarithmic transformation of the data.
Table 7
Fatty acid composition (g/100 g) of platelet phospholipids in the five experimental groupsd
Elaidic VaccenicFatty acid MCFA ANOVASAFA MUFA
Total
22.20.56a 22.40.60aC16:0 21.50.17a 24.60.24b 0.00523.20.40a
0.1163.21.7aC16:1 7.40.81a 3.41.4a3.00.68a 3.61.0a
19.20.79a 20.00.44aC18:0 21.41.7a 0.17621.32.0a 26.43.5a
0.00.00a 0.00.00a 0.00.00aC18:1 9t 5.80.17b 0.00.00a 0.001
0.0014.20.23b0.00.00a 0.00.00aC18:1 11t 0.00.00a0.00.00a
12.80.56a 13.40.09a 14.91.0aC18:1 9c 13.70.42a 13.20.20a 0.168
7.80.13ab 9.50.26c 6.60.49aC18:2 9c,12c 8.00.09ab 8.50.58bc 0.003
0.00.00a 0.00.00a 0.00.00aC18:2 9c,11t/9t,11c 0.00.00a 0.30.00b 0.001
C20:4 5c,8c,11c,14c 23.01.8a 24.30.85a 21.52.5a 22.80.08a 23.00.90a 0.780
2.00.07a 2.20.13a 2.40.17a 2.10.18aC22:6 4c,7c,10c,13c,16c,19c 2.50.22a 0.291
sn-2 position
0.78010.41.1a9.60.30a9.40.48a8.91.1a11.12.0aC16:0
1C16:1 11 11
10.53.5aC18:0 8.90.43a12.03.6a 9.71.6a 0.9219.73.9a
0.0010.00.00a0.80.04b0.00.00aC18:1 9t 0.00.00a0.00.00a
0.00.00a 0.00.00a 0.00.00a 0.00.00a 0.10.05a 0.091C18:1 11t
C18:1 9c 0.57517.50.47a18.20.21a19.20.96a17.50.58a18.11.0a
13.31.1a12.80.20a10.60.69a 0.13714.31.4a12.20.36aC18:2 9c,12c
C18:2 9c,11t/9t,11c 0.00.00a0.00.00a 0.00.00a 0.90.09b 0.0100.00.00a
41.14.4a 42.92.2a 44.01.3aC20:4 5c,8c,11c,14c 43.90.49a 41.51.1a 0.881
C22:6 4c,7c,10c,13c,16c,19c 3.20.12a 4.00.30a 4.20.25a 3.80.22a 4.30.61a 0.312
abc Groups not sharing the same superscript letter differ statistically significantly (P0.05, Student–Newman–Keul’s test).
d Analyses were performed per dietary group in three pools of washed platelets from eight hamsters each.
incorporation of vaccenic acid was negligible in the
hamsters on the Vaccenic diet. This difference was not
accompanied by differences between these two groups in
the level of arachidonic acid (C20:4, n-6) and docosahex-
aenoic acid (C22:6, n-3). Eicosapentaenoic acid (C20:5
n-3) was not observed in the phospholipids. Thus, levels
of eicosanoid precursors in the phospholipids did not
differ between the dietary groups. In the phospholipids
of the hamsters fed the Vaccenic diet, very low levels of
CLA were seen. Incorporation of CLA was mainly at the
sn-2 position.
4. Discussion
The purpose of this study was to investigate the effect
of the exchange of a high level (10 en%) dietary elaidic
acid as opposed to vaccenic acid on parameters of lipid
metabolism in vivo. The effects of the two trans-fatty
acids were also compared with those of their cis-counter-
part oleic acid, medium-chain fatty acids, and palmitic
acid in the diet. All diets contained a low background
level of cholesterol (0.01%) to enhance the effects of the
dietary fatty acids on blood (LDL-)cholesterol levels [13].
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In hamsters, dietary MCFA have been reported not to
increase LDL-cholesterol levels, whereas palmitic acid in
the diet was found to be hypercholesterolemic [6]. In the
current study, dietary fat-induced changes in blood
cholesterol levels were mainly reflected in LDL-choles-
terol concentrations. The absence of differential effects
of the dietary fatty acids on HDL-cholesterol levels in
hamsters has been observed by others as well [24]. In this
study palmitic acid tended to increase LDL-cholesterol
when compared with MCFA, supporting previous find-
ings [6], but this effect was not statistically significant.
Oleic acid in the diet has been reported to lower
LDL-cholesterol levels when compared with MCFA [24],
or myristic acid, which has similar effects as palmitic acid
in the hamster [6]. Also in our study oleic acid caused
significantly lower LDL-cholesterol levels than palmitic
acid, but the difference with the somewhat higher LDL-
cholesterol levels in the MCFA fed hamsters was not
statistically significant. Comparing MCFA, oleic and
myristic acid in hamsters, similar observations on blood
lipids as in the current study have been reported [25].
When palmitic acid or oleic acid was substituted for
MCFA, liver cholesterol concentrations in hamsters
have been reported to be lower or higher, respectively
[6,24]. Also in the current study, compared with the
MCFA diet, liver cholesterol concentrations tended to be
lower in hamsters on the palmitic acid-rich diet and were
very slightly higher after feeding the oleic acid-rich diet.
Plasma CETP activity levels, measured with exoge-
nous substrate as an estimate of CETP mass, were similar
after feeding the MCFA, palmitic acid, or oleic-acid rich
diets. This observation agrees well with that by Stein et
al. [26], who did not find a difference in CETP in
hamsters fed a diet with 15% margarine or 15% butter.
Consequently, the observed differences in the relative
levels of cholesteryl esters and triglycerides in VLDL are
probably not explained by dietary fatty acids-induced
effects on CETP activity. Indeed VLDL cholesteryl ester
levels were associated more with liver cholesterol concen-
trations. Although LCAT activity was higher in hamsters
fed the SAFA or Vaccenic diet, and lowest in those fed
the Elaidic diet, no differences were observed in the ratio
of cholesteryl esters over free cholesterol in HDL, nor in
HDL-cholesterol levels. Therefore, the consequence of
the observed differences in LCAT activity are not clear.
Remarkably, higher plasma PLTP activity in hamsters
fed the palmitic acid diet was associated with a higher
relative level of phospholipids in VLDL and LDL.
Currently the function of PLTP is hypothesized to be
modification of HDL subfractions [27] or transfer of
phospholipids from apo B containing lipoproteins to
HDL [28]. Higher levels of phospholipids in VLDL and
LDL are therefore not in line with the higher PLTP
activity, and can not be explained at present.
Thus, although in the current study the differences
were not always statistically significant, the effects on
lipid metabolism in the hamsters by dietary MCFA,
palmitic and oleic acid corresponded with the effects
observed by others in earlier hamster studies.
In man dietary trans-fatty acids have been reported to
simultaneously increase LDL-cholesterol and reduce
HDL-cholesterol when compared with oleic acid, or at
least raise the ratio LDL/HDL-cholesterol [10]. In ham-
sters fed ethyl–elaidate, plasma cholesterol was similar,
but LDL/HDL-cholesterol was higher and liver choles-
terol lower when compared with dietary ethyl–oleate
[29]. In another study using hamsters, dietary elaidic acid
caused lower liver cholesterol, and higher plasma LDL-
cholesterol levels when compared with oleic acid in the
diet [30]. In the present study, plasma total cholesterol
in the two trans-fatty acids fed groups did not differ from
that in the hamsters fed the MUFA diet. Also, Nicolosi
and co-workers did not observe differences in plasma
total cholesterol between hamsters fed trans-fatty acids
and those fed oleic acid [25]. LDL-cholesterol levels were
slightly, but not statistically significantly, higher in the
hamsters fed the Vaccenic diet than in their counterparts
fed the Elaidic or the MUFA diet. Thus, the effect of
dietary trans-fatty acids on LDL-cholesterol levels in the
hamsters varies between studies. In man plasma CETP
activity is increased when trans-fatty acids are substi-
tuted for oleic acid in the diet [11,12], which may
contribute to the increase in LDL-cholesterol and/or
reduction in HDL-cholesterol. However, CETP was not
affected by the dietary fatty acids in the current hamster
experiment. In humans consuming a diet with a very high
level of trans-fatty acids (8.7 en%), serum lipids have
been reported to contain increased amounts of CLA that
were not derived from the diet [31]. It was hypothesized
that CLA had been formed by an effect of 9-desaturase
on vaccenic acid from the trans-fatty acids-rich diet.
Indeed in the current study in hamsters fed vaccenic acid,
but not in those fed elaidic acid, CLA was present in liver
cholesteryl esters and platelet phospholipids, providing
support for this hypothesis.
The current study is the first to investigate the effects
of individual trans-fatty acids isomers on lipid
metabolism in vivo. When elaidic and vaccenic acid were
compared directly, this study revealed two main differ-
ences. The ratio of LDL/HDL-cholesterol in plasma was
significantly higher in hamsters fed vaccenic acid than in
their elaidic acid fed counterparts. Since this ratio is
associated positively with risk for coronary heart
disease in humans, the effect of vaccenic acid on blood
cholesterol could be considered worse than that of
elaidic acid. Elaidic acid was incorporated at low levels,
but more efficiently than vaccenic acid at the sn-2
position of platelet phospholipids. Eicosanoids are
derived from the elongation and desaturation products
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of polyunsaturated fatty acids. Eicosanoids are highly
active substances with diverse biological actions, also in
processes related to the development of coronary heart
disease such as thrombosis and inflammation. Levels of
arachidonic acid and docosahexaenoic acid in the phos-
pholipids of both groups fed trans-fatty acids was
similar. Eicosapentaenoic acid was not observed in the
phospholipids. Thus, levels of eicosanoid precursors in
the phospholipids did not differ between the dietary
groups. In addition, it seems unlikely that this differ-
ence at the observed level of total trans-fatty acids
incorporation in phospholipids has consequences for
the eicosanoid biosynthesis at an adequate linoleic acid
intake [32].
We conclude that the slight differences between
elaidic and vaccenic acid in their impact on lipid
metabolism do not support discrimination between
these two trans-fatty acid isomers in terms of effects
relevant for the pathogenesis of coronary heart disease.
Thus, this animal study does not provide evidence for
the suggestion, based on epidemiological observations
[1,2], that elaidic acid would be more detrimental for
cardiovascular risk than vaccenic acid.
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